Foundations like PHASE ONE, which support early phase clinical cancer research, are critical to translating novel findings from the lab into patient care. Thanks PHASE ONE Foundation for being excited about NK cell therapies! Rizwan Romee Dana-Farber
phaseonefoundation.org/latest-news/20…

With two of my favorite NK cell collaborators, friends and mentees at Farber, Dr Rebecca Porter (⁦Rebecca Porter⁩ ) leading our NK cell efforts in ovarian cancer and Dr Vincent Xu (⁦Wenxin (Vincent) Xu⁩ ) leading NK cell efforts in Kidney/Bladder cancer. ⁦Dana-Farber⁩

Excited to share new work on HSATII, a canonical example of #viralmimicry by repeats in our genome, with David Ting. Led by Rebecca Porter – who initiated this work, Siyu Sun & an amazing #teamscience effort with Mass General Cancer Center. Some brief comments 👇

jci.org/articles/view/…

See our new work showing satellite repeats are linked with #EMT and immune modulation in ovarian cancer led by Rebecca Porter Benjamin D. Greenbaum Siyu Sun jci.org/articles/view/…

Thanks also David Steensma, MD for the mentorship and support. Excited for this collaboration and grateful to Dunkin' for helping it happen